Shopping Cart
- Remove All
Your shopping cart is currently empty
Gilvetmab is a caninized anti-PD-1 monoclonal antibody that has obtained conditional approval for veterinary use in dogs. Gilvetmab is under active research for stage I, II, or III mast cell tumors and stage II or III melanoma. it is an competitive immune checkpoint inhibitor,attracting interests in the cancer research field.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $247 | In Stock | |
| 5 mg | $622 | In Stock | |
| 10 mg | $996 | In Stock | |
| 25 mg | $1,470 | In Stock | |
| 50 mg | $1,980 | In Stock |
| Description | Gilvetmab is a caninized anti-PD-1 monoclonal antibody that has obtained conditional approval for veterinary use in dogs. Gilvetmab is under active research for stage I, II, or III mast cell tumors and stage II or III melanoma. it is an competitive immune checkpoint inhibitor,attracting interests in the cancer research field. |
| Cas No. | 1808081-43-7 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.